Insulet filed an Addendum (Exhibit 10.1) effective Jan 1, 2026 to its Purchase Agreement with NXP USA, Inc.
Filed with the SEC on · Summarized by InvestorsBot
Insulet filed an Addendum (Exhibit 10.1) effective Jan 1, 2026 to its Purchase Agreement with NXP USA, Inc. (original agreement Oct 12, 2017). Certain portions are redacted as confidential. Current Report signed Feb 3, 2026. $PODD $NXPI 📝 #SECFilings #Insulet
No financial terms disclosed in the addendum; key details redacted. This likely updates Insulet’s supplier terms with chipmaker NXP—monitor for potential supply, cost or timing impacts on Pod devices. $PODD ⚠️ #SupplyChain #Insulet
Exhibit 10.1 filed with Inline XBRL cover page; portions omitted under SEC rules. Investors should watch upcoming 8-Ks/10-Qs for more detail or material financial impact from the NXP agreement change. $PODD 🔎 #SECFilings #Investing